Article Details
Retrieved on: 2021-06-29 13:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Briana Contreras: What is the rationale for the use of dual HER2-targeted monoclonal antibody therapy? Ian E. Krop, MD, PhD: There are now several ...
Article found on: www.managedhealthcareexecutive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here